Τόμος 9 (1995) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 9 (1995) – Issue 1 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

 

Title Subcutaneous bioavailability of carbisocaine in rats determinated by frequency response method
Authors M. Durisova¹, L. Dedik², L. Bohm², T. Trnovec³, Z. Kallay³ and V. Faberova⁴

1. Institute of Experimental Pharmacology, Slovak Academy of Sciences 842 16 Bratislava, Slovak Republic,

2. Faculty of Mechanical Engineering, Slovak Technical University, 812 31 Bratislava, Slovak Republic,

3. Institute of Preventive and Clinical Medicine, 833 01 Bratislava, Slovak Republic,

4. Drug Research Institute, 900 01 Modra, Slovak Republic

Citation Durisova, M., Dedik, L., Bohm, L., Trnovec, T., Kallay, Z.: Subcutaneous bioavailability of carbisocaine in rats determinated by frequency response method, Epitheorese Klin. Farmakol. Farmakokinet. 9(1): 25-31 (1995)
Publication Date Accepted for publication: 23 March 1995
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Frequency response method, weighting function, local anesthetics, subcutaneous administration, bioavailability, absorption kinetics, mean residence time.
Other Terms review article
Summary Carbisocaine, a prospective local anesthetic agent, was administered to rats intravenously and subcutaneously in a dose of 2.43 mg.kg-1. The optimal frequency model of the system describing carbisocaine pathway into the systemic circulation after subcutaneous administration, and point estimates of its parameters were selected using the CXT program and the frequency response method. The method is based on the approximation of the frequency response of the linear or linearized dynamic system, measured or calculated from input-output measurements, by the frequency model of the system transfer function, in the form of the ratio of the two frequency-dependent polynomials. The polynomials mentioned are general representatives of all models described by the sets of linear differentiaI equations with constant coefficients. The mean residence time of carbisocaine in the system studied was estimated on the basis of the selected system frequency model as 392.4 min. The estimation of the extent of carbisocaine subcutaneous bioavailability yielded the value of 0.434. The system weighting function describing the rate of carbisocaine subcutaneous bioavailability was estimated in an analytical form. This showed four distinctive phases and a rapid initial peak of nearly 0.0017 units dose/min, recorded approximately 2.5 min after the drug administration.
References 1.         Akaike, H.: Canonical correlation analysis of time series and the use of an information criterion System Identification. In: Advances and Case Studies (Mehra, R.,K., Lainiotis, D.,G., eds.), pp. 27-93, London, Academic Press, 1976

2.        Benes, L., Borovansky, A., Svec, P., Stolc, S., Stankovicova, T.: CS Patent 208960 (1979)

3.        Bezek, S., Faberova, V., Scasnar, V., Trnovec, T., Durisova, M., Kallay, Z.: Pharmacokinetics of carbisocaine in rats and mice. Eur. J. Drug. Metab. Pharmacokinet. 13: 27-34 (1988)

4.        Dedik, L., Durisova, M.: Frequency response method in pharmacokinetics. J. Pharmacokin. Biopharm. 22: 293-307 (1994)

5.        Dedik, L., Durisova, M.: CXT program – applications in analysis of continuous dynamic systems. Proceedings of the International Sommerkurs 1994, Technische Univerisität Wien, Institut für Handhabungsgeräte und Robotertechnik Ausseninstitut, Krems, 1994

6.        Dedik, L., Durisova, M.: CXT – A program for analysis of linear dynamic systems in the frequency domain. Int. J. Bio-Med. Comput. (accepted, in press), 1995

7.         Durisova, M., Dedik, L.: Comparative study of human pentacaine pharmacokinetics in time and frequency domain. Meth. Find. Exp. Clin. Pharmacol. 16: 219-232 (1994)

8.        Durisova, M., Dedik, L., Balan, M.: Building of a structure model of a complex pharmacokinetic system with time delay. Bull. Math. Biol, (accepted, in press), 1995

9.        Elbert. T., Marko, V., Filip, J., Benes, L.: Synthesis of C labelled heptacaine, new local anaesthetic. Labeled Comp. Radiopharm. 2: 101-109 (1983)

10.      Grundbegrife der Messtechnik Behaitung von Unsicherheiten bei der Auswertung von Messungen, DIN 1319, Berlin, 1985

11.       Guide to the Expression of Uncertainty in Measurement, ISO, Berne, 1993

12.      Levy, E.C.: Complax curve fitting. IRE Trans. Automat. Contr. 4: 37-43 (1959)

13.      Noonan, P., K., Wester, R., C.: Cutaneous metabolism of xenobiotics. In: Percutaneous Absorption (Bropnaugh, R., L., Maibach, H., I., eds), pp. 65-85, New York, Marcel Dekker, 1985

14.      Schoukens, J., Pinteion, R.: Identification of linear systems. A Practical Guide for Accurate Modelling, London, Pergamon Press, 1991

15.      Singh, M. G.: Systems and Control Encyclopedia, Theory, Technology and Application, Oxford, Pergamon Press, 1987

16.      Stankovicova, T. Stoic, S., Szöcsova, H., Benes, L.: pH dependence of the biological activity of carbisocaine and its derivatives, Drugs Exptl. Clin. Res. 12: 761-764 (1986)

17.       Scott, D., B.: Toxic effects of local anaesthetic agents on the central nervous system. Br. J. Anaesth. 53: 732-735 (1986)

18.      Scasnar, V., Benes, L. Bezek, S., and Trnovec, T.: Simple radiochemical procedure for quantitative and selective determination of carbisocaine in biological material. Pharmaze 40: 268-269 (1985)

19.      Tucker, G.,T., Mather, L.,E.: Clinical pharmacokinetics of local anaesthetics. Clin. Pharmacokin. 4: 241-278 (1979)

20.      Stolc, S., Stankovicova, T.: Effect of local anaesthetics and pH: new aspects. Drugs Exptl. Clin. Res. 12: 753-760 (1986)

21.      van Rossum, J., M., de Bie, J., E.,G.,M., van Lingen, G., Teeuwen, H., W., A.: Pharmacokinetics from dynamic systems point of view. J. Pharmacokin. Biopharm. 17: 365-392 (1988)

22.      Wagner, J.,G.: Do you need a pharmacokinetic model, and, if so which one? J. Pharmacokin. Biopharm. 3: 457-478 (1975)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1995 – ANNUAL SUBSCRIPTION 1995
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

Bookmark the permalink.

Comments are closed.